相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Taroh Satoh et al.
CLINICAL CANCER RESEARCH (2009)
Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer
Giuseppe Giaccone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines
Tsutomu Iwasa et al.
CLINICAL CANCER RESEARCH (2008)
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells
Nand K. Sah et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Molecular analysis of survivin isoforms - Evidence that alternatively spliced variants do not play a role in mitosis
EA Noton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer
F Rödel et al.
CANCER RESEARCH (2005)
Survivin splice variants regulate the balance between proliferation and cell death
H Caldas et al.
ONCOGENE (2005)
Survivin 2α:: a novel survivin splice variant expressed in human malignancies
Hugo Caldas et al.
MOLECULAR CANCER (2005)
Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts
CP Diggle et al.
NUCLEIC ACIDS RESEARCH (2005)
Identification of a novel splice variant of the human anti-apoptosis gene survivin
A Badran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy
N Taneja et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms
A Chakravarti et al.
ONCOGENE (2004)
Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm
DC Altieri
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines
JP Banáth et al.
CANCER RESEARCH (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
HBXIP functions as a cofactor of survivin in apoptosis suppression
H Marusawa et al.
EMBO JOURNAL (2003)
Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin
S De Schepper et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Differential subcellular localization of functionally divergent survivin splice variants
C Mahotka et al.
CELL DEATH AND DIFFERENTIATION (2002)
Expression of different survivin variants in gastric carcinomas:: first clues to a role of survivin-2B in tumour progression
A Krieg et al.
BRITISH JOURNAL OF CANCER (2002)
The molecular basis and potential role of survivin in cancer diagnosis and therapy
DC Altieri
TRENDS IN MOLECULAR MEDICINE (2001)
ATM, a central controller of cellular responses to DNA damage
KK Khanna et al.
CELL DEATH AND DIFFERENTIATION (2001)
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.
M Milella et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis
SP Wheatley et al.
CURRENT BIOLOGY (2001)
Cytokine-regulated expression of survivin in myeloid leukemia
BZ Carter et al.
BLOOD (2001)
Inhibition of melanoma tumor growth in vivo by survivin targeting
D Grossman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
DNA damage-induced activation of p53 by the checkpoint kinase Chk2
A Hirao et al.
SCIENCE (2000)
分享论文
